Seattle Genetics says leukemia drug fails trial - Reuters

[INCIID News Feed]

Genetic Engineering News
<img alt="" height="1" width="1" />
Seattle Genetics says leukemia drug fails trial
Reuters
LOS ANGELES, Sept 13 (Reuters) - Seattle Genetics (SGEN.O) said a key trial of its experimental drug lintuzumab showed that the biotechnology treatment did not extend the lives of patients with acute myeloid leukemia, ...
Seattle Genetics leukemia drug fails studyBusinessWeek
Seattle Genetics Shares Drop As Trial Of Leukemia Drug FailsWall Street Journal
Seattle Genetics will shelve AML drug after PhIIb failureFierceBiotech
Genetic Engineering News -New York Times (blog) -Puget Sound Business Journal
all 52 news articles &raquo;


More...